BSGM Stock Overview
A medical device company, engages in development and commercialization of advanced digital signal processing technology platform for the treatment of cardiovascular arrhythmias in the United States.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
+ 2 more risks
BioSig Technologies, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$2.03 |
| 52 Week High | US$15.50 |
| 52 Week Low | US$0.26 |
| Beta | 0.70 |
| 1 Month Change | 18.71% |
| 3 Month Change | 207.58% |
| 1 Year Change | -82.94% |
| 3 Year Change | -94.73% |
| 5 Year Change | -97.03% |
| Change since IPO | -97.47% |
Recent News & Updates
Recent updates
Shareholders May Be More Conservative With BioSig Technologies, Inc.'s (NASDAQ:BSGM) CEO Compensation For Now
Dec 12
Shareholders May Not Be So Generous With BioSig Technologies, Inc.'s (NASDAQ:BSGM) CEO Compensation And Here's Why
Dec 14BioSig in acquisition pact with San Antonio Hospital for cardiac signal system
Oct 07BioSig: No Changes To Hold Thesis Following Q2 Earnings
Sep 08BioSig signs purchase deal with Kansas City's Overland Park Regional hospital
Jul 07BioSig: PURE EP Economics Trade Exhausted
Jun 14Companies Like BioSig Technologies (NASDAQ:BSGM) Could Be Quite Risky
Mar 22Here's Why BioSig Technologies (NASDAQ:BSGM) Must Use Its Cash Wisely
Dec 02Shareholder Returns
| BSGM | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 17.3% | -0.8% | -0.6% |
| 1Y | -82.9% | 1.9% | 22.5% |
Return vs Industry: BSGM underperformed the US Medical Equipment industry which returned 1.9% over the past year.
Return vs Market: BSGM underperformed the US Market which returned 22.5% over the past year.
Price Volatility
| BSGM volatility | |
|---|---|
| BSGM Average Weekly Movement | 39.4% |
| Medical Equipment Industry Average Movement | 7.8% |
| Market Average Movement | 5.8% |
| 10% most volatile stocks in US Market | 15.7% |
| 10% least volatile stocks in US Market | 2.9% |
Stable Share Price: BSGM's share price has been volatile over the past 3 months.
Volatility Over Time: BSGM's weekly volatility has increased from 27% to 39% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2009 | 4 | Anthony Amato | www.biosig.com |
BioSig Technologies, Inc., together with its subsidiaries, a medical device company, engages in development and commercialization of advanced digital signal processing technology platform for the treatment of cardiovascular arrhythmias in the United States. It offers PURE EP system, a signal processing platform that combines hardware and software to address known challenges associated to signal acquisition that enables electrophysiologists to see signals and analyze in real-time, as well as is designed to address long-standing limitations that slow and disrupt cardiac catheter ablation procedures. The company has a research agreement with Mayo Foundation to develop an AI- and machine learning-powered software for PURE EP system.
BioSig Technologies, Inc. Fundamentals Summary
| BSGM fundamental statistics | |
|---|---|
| Market cap | US$28.39m |
| Earnings (TTM) | -US$25.25m |
| Revenue (TTM) | US$27.00k |
1,062x
P/S Ratio-1.1x
P/E RatioIs BSGM overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BSGM income statement (TTM) | |
|---|---|
| Revenue | US$27.00k |
| Cost of Revenue | US$0 |
| Gross Profit | US$27.00k |
| Other Expenses | US$25.28m |
| Earnings | -US$25.25m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -1.79 |
| Gross Margin | 100.00% |
| Net Profit Margin | -93,529.63% |
| Debt/Equity Ratio | -11.9% |
How did BSGM perform over the long term?
See historical performance and comparison